In 2015, the global health and development community will collectively assess the progress of nations towards achieving the Millennium Development Goals (MDGs), an ambitious framework for human development based on broad principles of equity, solidarity and poverty reduction. Of the 12 goals established to measure social and economic progress, three (MDG4, MDG5 and MDG6) relate directly to health development; reduction of child mortality, reduction of maternal mortality; and progress against the global epidemics of HIV/AIDS, malaria and tuberculosis, respectively. 1 There has been much debate about whether global goals with explicit targets are useful or not in stimulating action by countries and donors to improve health. Whereas broad development goals are likely to receive strong endorsement by countries, the addition of specific targets might well be unwelcome, particularly if they are perceived as being too ambitious. Worse, the global focus on targets for the MDGs has driven a culture of accountability with an almost singular focus on whether a country is likely to achieve the specified targets or not, to the detriment of other important measures of progress. The political imperative that countries have no doubt felt to accelerate progress with health development because of the existence of the MDGs is laudable, and real, but it has not necessarily been the ideal policy environment to do so, for five principal reasons. First, recent global assessments have suggested that only about one-quarter of all countries, and less than one in five developing countries, will achieve MDGs 4 and 5, obscuring the very substantial progress in reducing child mortality, for example, that has occurred in sub-Saharan Africa, India and much of eastern Europe since 2000. [2] [3] [4] In many countries, these accelerated declines have been due to the success of bold public policies, and financing, to scale-up and ensure delivery of bed nets and effective treatments to control diarrhoea and vaccine-preventable diseases, to manage HIV infection through antiretroviral therapy (ART) and prevent mother-to-child transmission of the virus. [5] [6] [7] [8] [9] Yet, there is comparatively little awareness or focus on these impressive gains in reducing child mortality since they are, in most cases, unlikely to lead to countries achieving the global target. Arguably, the policy intelligence that can be gleaned from the success stories of the past 12-15 years ought to be the principal concern of the global health development community, and not whether a country might, or might not achieve some arbitrary target. The arbitrariness of global target-setting is the second major concern. In order to achieve MDG4, for example, child mortality would need to have declined by an annual average of 4.4% from its baseline (1990) value. Very few countries have experienced declines in child mortality of this magnitude over any given 5-year period and indeed, there was little evidence to suggest such optimism in the period leading up to the formulation of the MDG targets. From 1970 to 1985, child mortality rates worldwide fell on average by about 2.6% per year, with more modest declines over the next decade, and then accelerated again from 1995 to 2005 when the global average rate of decline reached 4%. 3 Around the time that the MDG targets were established (2000), the rate of decline was about 3%, or only about two-thirds of what was prescribed. Whereas setting challenging and aspirational targets in global health may well be motivational and lead to increased performance in controlling major diseases and injuries, the experience with the MDGs suggests that that is not always, nor indeed often, the case. A more comprehensive review of the epidemiological and demographic evidence over the two decades or so preceding the establishment of the targets would have suggested a more conservative global target that was within the reach of most countries. Third, the MDG health-related targets make no explicit mention of the need to hold countries, and the global development community more generally, accountable for what should have been a primary focus of their collective action, namely to reduce inequalities in health. It is hard to imagine an informed global strategy to reduce poverty not depending on some measure of progress in reducing health inequalities, particularly for maternal and child health. Yet in the MDGs there is none, and hence any assessment of the extent to which the MDGs have led to a reduction in poverty must depend on other sources and analyses. To the extent that the MDGs, and particularly over the past decade or so, have led to more, and more effective, action by countries and donors to improve survival and reduce disease burden, the failure of the MDGs to include a measure of health inequalities is a missed opportunity.
Presumably the lack of any measure or target related to inequalities in population health was due to the lack of available data at the time the targets were set to reliably measure progress. This raises the fourth, and in my view the most serious, limitation of the MDG target-setting enterprise, namely the failure of the process to more effectively champion countries, donors and global health institutions, particularly the World Health Organization, to improve country health information systems to ensure that they can more reliably support health development policies and programmes. The deplorable state of mortality information, particularly civil registration and vital statistics (CRVS) systems, at the beginning of the MDG era is lamentable but perhaps understandable in the absence of prior strategic investments; the equally deplorable state of CRVS systems 15 years later, despite their obvious relevance as the most appropriate source of continuous, detailed, disaggregated and comparable epidemiological data, is not. 10, 11 Fifth, although a focus on the unfinished agenda around maternal and child health, and on the pressing major global health challenges arising from HIV/AIDS, tuberculosis and malaria, was certainly appropriate, it was arguably not enough. Evidence accumulating over the later part of the 20th century, through careful epidemiological studies in large developing populations, was clearly pointing to the massive impending effect of tobacco on the health of these populations. Yet policy action to control its use was demonstrably inadequate, almost guaranteeing a rise in mortality from major non-communicable diseases (NCDs) among men in developing countries in our lifetime. 12 The rise of obesity in many developing countries is likely to exacerbate this impact, particularly where health systems are too poorly financed and organized to deliver effective treatments to adequately cope with the pathological consequences of excess body weight or poor diet, especially raised blood pressure and glucose intolerance. 13 Already, by the turn of the century, non-communicable diseases were by far the leading causes of death and premature death virtually throughout the developing world, and have continued to rise as a proportion of all deaths, yet are conspicuously absent from the MDG framework. 14 So too are leading causes of injury worldwide, particularly road traffic injuries, which are estimated to have killed 1.4 million people in 2013 (many of them at young ages), one-third more than in 1990 when the MDG era began. 14 The median percentage decline worldwide in age-standardized mortality rates from communicable, maternal, neonatal and nutritional conditions between 1990 and 2013 was estimated to be 40.6%, twice as great as for non-communicable diseases (18.6%) and injuries (21.0%). 14 Including targets for reducing mortality from these diseases and injuries may not have led to sufficient policy action to bring rates down faster, but it almost certainly would have contributed to raising awareness among key global health stakeholders about the urgent need to accelerate the implementation of known, effective interventions against major NCDs and injuries. The same applies to leading causes of disability, which are absent from the MDG framework. Successive Global Burden of Disease studies have suggested that about one-third of health loss worldwide arises from largely non-fatal conditions, particularly mental health disorders. 15 Societies collectively invest substantial resources in keeping people healthy, not just on keeping them alive; the inclusion of a measure of population mental health, for example, among the MDG targets would have provided key intelligence about how well we are doing in treating and preventing disability. 16 If the incorporation of epidemiological evidence and measurement science into setting goals and targets for the MDGs was less than optimal, how might a more careful consideration of epidemiological research and findings be better used to influence current debates and proposals for inclusion of a health goal and targets for the Sustainable Development Goals (SDGs) which will replace them? Five broad principles are proposed to guide such debates:
i. Targets should be based on epidemiological evidence about observed rates of change in epidemiological parameters most relevant to describing a population's health today, and how it is likely to evolve given current trends. ii. While acknowledging that human development is multifactorial, the role of the health sector in ensuring healthy populations is central to development. Any indicator or target intended to capture health development should therefore focus on measuring health loss in populations, not on vague and poorly defined notions of well-being. iii. Targets should explicitly take into account epidemiological evidence and research about the relationships between exposure to health hazards and disease and injury outcomes, and the dynamics of how population exposure to these risks is changing, when setting future targets for mortality and disability. iv. Indicators proposed to assess progress towards health targets should focus on what is measureable, with reasonable confidence, and be accompanied by explicit strategies to improve health information systems to more reliably generate these essential data, drawing on the potential of new, cost-effective data collection technologies and diagnostic methods. [17] [18] [19] [20] v. Goals and targets ought to explicitly reflect the moral obligation to improve health among the less well off as a priority. We all ought to be accountable for doing so. Explicitly including measures of population exposure to key health hazards, and access to essential health services, among the poor will be as important in predicting transitions out of poverty as current, often poorly based, estimates of mortality inequalities.
Adherence to these principles will greatly strengthen the scientific basis for proposing and monitoring development goals and targets, and assessing how well we collectively have done in meeting them. Global development partners and countries alike need to be more cognizant of the critical role that epidemiological research, both descriptive and analytical, can play in the formulation and implementation of health development strategies. Equally, epidemiologists have a responsibility to more effectively communicate to the global development community what are the leading causes of death in populations, how certain we are about them, and what our research suggests are important and feasible interventions to address them. 
